CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- 4 Grant or award Chief Legal Officer acquired 42,403 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise SVP, FINANCE, CHIEF ACCT OFFCR acquired 10,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 2,151 shares at $41.98 ($90,307)
- 4 Open-market sale SVP, FINANCE, CHIEF ACCT OFFCR sold 3,117 shares at $41.98 ($130,864)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 4,949 shares at $41.98 ($207,778)
- 4 Open-market sale PRESIDENT AND CEO sold 16,925 shares at $41.98 ($710,578)
- 4 Open-market sale Chief Operating Officer sold 2,579 shares at $41.98 ($108,276)
- 4 Open-market sale Chief Regulatory Officer sold 2,187 shares at $41.98 ($91,819)
- 4 Open-market sale Chief Commercial Officer sold 1,582 shares at $41.98 ($66,419)
- 4 Grant or award SVP, FINANCE, CHIEF ACCT OFFCR acquired 10,000 shares (grant or award)
- 4 Grant or award PRESIDENT AND CEO acquired 68,800 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Regulatory Officer acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 2 of 12 · 230 filings